Global and China Paediatric Vaccine Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Paediatric Vaccine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Pneumococcal
  • 1.2.3 Varicella
  • 1.2.4 Combinations
  • 1.2.5 Poliovirus
  • 1.2.6 Hepatitis
  • 1.2.7 MMR
  • 1.2.8 Pediatric Hormones
  • 1.2.9 HIB
  • 1.2.10 Allergy and Respiratory vaccines
  • 1.2.11 Other Pediatric vaccines
• 1.3 Market by Application
  • 1.3.1 Global Paediatric Vaccine Market Share by Application: 2020 VS 2026
  • 1.3.2 Age (0-3)
  • 1.3.3 Age (3-12)
  • 1.3.4 Age Above 12
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Paediatric Vaccine Market Perspective (2015-2026)
• 2.2 Global Paediatric Vaccine Growth Trends by Regions
  • 2.2.1 Paediatric Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Paediatric Vaccine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Paediatric Vaccine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Paediatric Vaccine Players by Market Size
  • 3.1.1 Global Top Paediatric Vaccine Players by Revenue (2015-2020)
  • 3.1.2 Global Paediatric Vaccine Revenue Market Share by Players (2015-2020)
• 3.2 Global Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Paediatric Vaccine Revenue
• 3.4 Global Paediatric Vaccine Market Concentration Ratio
  • 3.4.1 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Paediatric Vaccine Revenue in 2019
• 3.5 Key Players Paediatric Vaccine Area Served
• 3.6 Key Players Paediatric Vaccine Product Solution and Service
• 3.7 Date of Enter into Paediatric Vaccine Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Paediatric Vaccine Breakdown Data by Type (2015-2026)

• 4.1 Global Paediatric Vaccine Historic Market Size by Type (2015-2020)
• 4.2 Global Paediatric Vaccine Forecasted Market Size by Type (2021-2026)

5 Paediatric Vaccine Breakdown Data by Application (2015-2026)

• 5.1 Global Paediatric Vaccine Historic Market Size by Application (2015-2020)
• 5.2 Global Paediatric Vaccine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Paediatric Vaccine Market Size (2015-2026)
• 6.2 North America Paediatric Vaccine Market Size by Type (2015-2020)
• 6.3 North America Paediatric Vaccine Market Size by Application (2015-2020)
• 6.4 North America Paediatric Vaccine Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Paediatric Vaccine Market Size (2015-2026)
• 7.2 Europe Paediatric Vaccine Market Size by Type (2015-2020)
• 7.3 Europe Paediatric Vaccine Market Size by Application (2015-2020)
• 7.4 Europe Paediatric Vaccine Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Paediatric Vaccine Market Size (2015-2026)
• 8.2 China Paediatric Vaccine Market Size by Type (2015-2020)
• 8.3 China Paediatric Vaccine Market Size by Application (2015-2020)
• 8.4 China Paediatric Vaccine Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Paediatric Vaccine Market Size (2015-2026)
• 9.2 Japan Paediatric Vaccine Market Size by Type (2015-2020)
• 9.3 Japan Paediatric Vaccine Market Size by Application (2015-2020)
• 9.4 Japan Paediatric Vaccine Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Paediatric Vaccine Market Size (2015-2026)
• 10.2 Southeast Asia Paediatric Vaccine Market Size by Type (2015-2020)
• 10.3 Southeast Asia Paediatric Vaccine Market Size by Application (2015-2020)
• 10.4 Southeast Asia Paediatric Vaccine Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 GlaxoSmithCline
  • 11.1.1 GlaxoSmithCline Company Details
  • 11.1.2 GlaxoSmithCline Business Overview
  • 11.1.3 GlaxoSmithCline Paediatric Vaccine Introduction
  • 11.1.4 GlaxoSmithCline Revenue in Paediatric Vaccine Business (2015-2020))
  • 11.1.5 GlaxoSmithCline Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Merck Business Overview
  • 11.2.3 Merck Paediatric Vaccine Introduction
  • 11.2.4 Merck Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.2.5 Merck Recent Development
• 11.3 Sanofi
  • 11.3.1 Sanofi Company Details
  • 11.3.2 Sanofi Business Overview
  • 11.3.3 Sanofi Paediatric Vaccine Introduction
  • 11.3.4 Sanofi Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.3.5 Sanofi Recent Development
• 11.4 Bristol-Myers Squibb
  • 11.4.1 Bristol-Myers Squibb Company Details
  • 11.4.2 Bristol-Myers Squibb Business Overview
  • 11.4.3 Bristol-Myers Squibb Paediatric Vaccine Introduction
  • 11.4.4 Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.4.5 Bristol-Myers Squibb Recent Development
• 11.5 Abbott Laboratories
  • 11.5.1 Abbott Laboratories Company Details
  • 11.5.2 Abbott Laboratories Business Overview
  • 11.5.3 Abbott Laboratories Paediatric Vaccine Introduction
  • 11.5.4 Abbott Laboratories Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.5.5 Abbott Laboratories Recent Development
• 11.6 Eli Lilly
  • 11.6.1 Eli Lilly Company Details
  • 11.6.2 Eli Lilly Business Overview
  • 11.6.3 Eli Lilly Paediatric Vaccine Introduction
  • 11.6.4 Eli Lilly Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.6.5 Eli Lilly Recent Development
• 11.7 Pfizer
  • 11.7.1 Pfizer Company Details
  • 11.7.2 Pfizer Business Overview
  • 11.7.3 Pfizer Paediatric Vaccine Introduction
  • 11.7.4 Pfizer Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.7.5 Pfizer Recent Development
• 11.8 F. Hoffmann-La Roche
  • 11.8.1 F. Hoffmann-La Roche Company Details
  • 11.8.2 F. Hoffmann-La Roche Business Overview
  • 11.8.3 F. Hoffmann-La Roche Paediatric Vaccine Introduction
  • 11.8.4 F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.8.5 F. Hoffmann-La Roche Recent Development
• 11.9 Novo Nordisk
  • 11.9.1 Novo Nordisk Company Details
  • 11.9.2 Novo Nordisk Business Overview
  • 11.9.3 Novo Nordisk Paediatric Vaccine Introduction
  • 11.9.4 Novo Nordisk Revenue in Paediatric Vaccine Business (2015-2020)
  • 11.9.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer